HomeNASDAQ:NVAX

NASDAQ:NVAX

Novavax Stock Soars Nearly 300% in One Month

June 7, 2024

Novavax Faces Uphill Battle, Forecasts Flat to Lower Sales in 2024

Novavax Faces Uphill Battle, Forecasts Flat to Lower Sales in 2024

February 28, 2024

Novavax Surpasses Revenue Estimates, Eyes Further Cost Reductions

Novavax Surpasses Revenue Estimates, Eyes Further Cost Reductions

November 9, 2023

Novavax Expands Its Vaccine Portfolio Amidst Evolving Landscape

Novavax Expands Its Vaccine Portfolio Amidst Evolving Landscape

October 10, 2023

Is It Too Late to Invest in Novavax Stock?

Is It Too Late to Invest in Novavax Stock?

October 20, 2022

Novavax Stock: Explaining Wednesday’s Decline

Novavax Stock: Explaining Wednesday’s Decline

October 19, 2022

Novavax Stock Drops As JPMorgan Cuts Its Long-Term Prognosis

Novavax Stock Drops As JPMorgan Cuts Its Long-Term Prognosis

September 22, 2022

Novavax Stock Remains a Risk-on Stock in a Risk-off Market

September 22, 2022

Novavax Developed COVID-19 Vaccine Has Been Approved by The Swiss Government

Novavax Developed COVID-19 Vaccine Has Been Approved by The Swiss Government

September 5, 2022

Novavax Experiences a 52-Week Low as Pfizer and Moderna Receive FDA Approval for Improved Boosters

Novavax Experiences a 52-Week Low as Pfizer and Moderna Receive FDA Approval for Improved Boosters

August 31, 2022

1 2 »